Stock Updates: Cyclo Therapeutics, Lucy Scientific, Pasithea Therapeutics and Apple Making Waves
- June 05th, 2023
- 398 views
Cyclo Therapeutics, Inc. (Nasdaq: CYTH) has entered into a binding agreement with Rafael Holdings, Inc. (NYSE: RFL).
Under the agreement, Rafael will acquire 4,000,000 shares of CYTH's common stock, along with warrants to purchase an additional 4,000,000 shares, for a total purchase price of $5,000,000.
$CYTH is currently trading at $1.42, reflecting a slight increase of $0.01 (+0.71%).
In other news, Lucy Scientific Discovery Inc. (Nasdaq: LSDI) has made a proposal to acquire Pasithea Therapeutics Corp. (Nasdaq: KTTA) through a cash-and-stock transaction.
The proposal suggests a per-share acquisition price of $0.85, comprising $0.60 in cash and $0.25 in Lucy stock.
Trading for both $LSDI and $KTTA has been halted in light of this development.
Additionally, BofA Securities has raised the price target for Apple Inc. (Nasdaq: AAPL) from $176 to $190, while Evercore ISI Group increased it from $190 to $210.
Currently, $AAPL is trading at $183.58, reflecting a positive movement of $2.63 (+1.45%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
NJCP Football League Provides Development and Opportunity for Athletes Pursuing the Next Level
March 20th, 2026March 19th, 2026How High School Graduates Can Kickstart Their Football Career
March 18th, 2026
Member Login